> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Cipla India Plant Receives FDA-483
- URL: https://www.fdaweb.com/cipla-india-plant-receives-fda-483/
- Published: 2022-08-19T12:00:00.000Z
- Updated: 2026-09-14T17:56:35.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5152551

India-based Cipla Ltd. has been issued a two-item Form FDA-483 after a 6/27-7/1 FDA inspection at its Madhya Pradesh, India manufacturing plant. According to the [inspection form](https://www.fda.gov/media/160987/download?ref=fdaweb.com), the firm was cited for:

- Equipment and utensils not being cleaned and maintained at appropriate intervals to prevent
- Drug product samples for determining conformance to written specifications are not being properly identified.